In the last trading session, 1.3 million Milestone Pharmaceuticals Inc (NASDAQ:MIST) shares changed hands as the company’s beta touched 1.82. With the company’s per share price at $1.80 changed hands at -$0.09 or -4.76% during last session, the market valuation stood at $95.99M. MIST’s last price was a discount, traded about -52.78% off its 52-week high of $2.75. The share price had its 52-week low at $1.12, which suggests the last value was 37.78% up since then.
Analysts gave the Milestone Pharmaceuticals Inc (MIST) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MIST as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Milestone Pharmaceuticals Inc’s EPS for the current quarter is expected to be -0.15.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Instantly MIST was in red as seen at the end of in last trading. With action -18.55%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -23.73%, with the 5-day performance at -18.55% in the red. However, in the 30-day time frame, Milestone Pharmaceuticals Inc (NASDAQ:MIST) is -12.20% down.
The consensus price target for the stock as assigned by Wall Street analysts is 10, meaning bulls need an upside of 82.0% from its current market value. According to analyst projections, MIST’s forecast low is 10 with 10 as the target high. To hit the forecast high, the stock’s price needs a -455.56% plunge from its current level, while the stock would need to soar -455.56% for it to hit the projected low.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
Year-over-year growth is forecast to reach -100.00% down from the last financial year.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -7.22%. The 2025 estimates are for Milestone Pharmaceuticals Inc earnings to increase by 54.82%, but the outlook for the next 5-year period is at 26.29% per year.
MIST Dividends
Milestone Pharmaceuticals Inc is expected to release its next quarterly earnings report in March.
RTW INVESTMENTS, LP holds the second largest percentage of outstanding shares, with 4.9211% or 3.26 million shares worth $4.3 million as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF and Fidelity NASDAQ Composite Index Fund . With 19.12 shares estimated at $34410.0 under it, the former controlled 0.04% of total outstanding shares. On the other hand, Fidelity NASDAQ Composite Index Fund held about 0.04% of the shares, roughly 19.87 shares worth around $35769.0.
